We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.66%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$455B
AUM Growth
+$26.6B
Cap. Flow
-$26.7B
Cap. Flow %
-5.87%
Top 10 Hldgs %
33.25%
Holding
16,292
New
1,466
Increased
6,223
Reduced
6,687
Closed
1,652

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$645M
2
TMUS icon
T-Mobile US
TMUS
+$640M
3
T icon
AT&T
T
+$517M
4
HUM icon
Humana
HUM
+$481M
5
BSX icon
Boston Scientific
BSX
+$400M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.24B
2
AAPL icon
Apple
AAPL
+$755M
3
META icon
Meta Platforms (Facebook)
META
+$707M
4
CAT icon
Caterpillar
CAT
+$472M
5
AMD icon
Advanced Micro Devices
AMD
+$449M

Sector Composition

Rank Sector Weight
1 Healthcare 3.33%
2 Technology 3.2%
3 Financials 2.22%
4 Industrials 2.17%
5 Consumer Discretionary 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RPT
13151
CALL
Rithm Property Trust
RPT
$104M
$15.8K ﹤0.01%
400
-17
-4% -$807
DZSI
13152
PUT
DELISTED
DZS Inc. Common Stock
DZSI
$15.8K ﹤0.01%
2,000
+1,900
+1,900% +$21.1K
EVC icon
13153
PUT
Entravision Communication
EVC
$832M
$15.7K ﹤0.01%
2,600
+1,100
+73% +$6.81K
AQMS icon
13154
CALL
Aqua Metals
AQMS
$9.99M
$15.7K ﹤0.01%
79
+11
+16% +$2.57K
IBIO icon
13155
iBio
IBIO
$71M
$15.7K ﹤0.01%
377
XFOR icon
13156
X4 Pharmaceuticals
XFOR
$418M
$15.6K ﹤0.01%
599
-30,896
-98% -$906K
CHKP icon
13157
Check Point Software Technologies
CHKP
$13.4B
$15.6K ﹤0.01%
120
-1,677
-93% -$213K
CYTH
13158
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
$15.6K ﹤0.01%
+18,501
New +$26.3K
EQ icon
13159
CALL
Equillium
EQ
$150M
$15.5K ﹤0.01%
21,300
-15,800
-43% -$15.1K
UFI icon
13160
PUT
UNIFI
UFI
$120M
$15.5K ﹤0.01%
1,900
-16,400
-90% -$146K
RTB
13161
PUT
RTB Digital
RTB
$237M
$15.5K ﹤0.01%
108
-23
-18% -$4.17K
LUXE
13162
PUT
LuxExperience B.V.
LUXE
$1.05B
$15.5K ﹤0.01%
2,200
+500
+29% +$4.54K
VINP icon
13163
PUT
Vinci Compass Investments Ltd
VINP
$626M
$15.4K ﹤0.01%
+1,900
New +$17.7K
ESMT
13164
PUT
DELISTED
EngageSmart, Inc.
ESMT
$15.4K ﹤0.01%
800
+500
+167% +$9.67K
CTIC
13165
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$15.4K ﹤0.01%
3,662
-47,649
-93% -$247K
CGEM icon
13166
PUT
Cullinan Oncology
CGEM
$1.31B
$15.3K ﹤0.01%
1,500
+1,200
+400% +$13.2K
KARS icon
13167
PUT
KraneShares Electric Vehicles and Future Mobility Index ETF
KARS
$80.7M
$15.3K ﹤0.01%
+500
New +$15.5K
MWA icon
13168
PUT
Mueller Water Products
MWA
$3.99B
$15.3K ﹤0.01%
+1,100
New +$14.3K
KRON
13169
CALL
DELISTED
Kronos Bio
KRON
$15.3K ﹤0.01%
10,500
+10,100
+2,525% +$19.4K
EHAB
13170
PUT
DELISTED
Enhabit
EHAB
$15.3K ﹤0.01%
1,100
-4,300
-80% -$61.8K
CRCT icon
13171
PUT
Cricut
CRCT
$1.21B
$15.3K ﹤0.01%
1,500
+1,200
+400% +$11.6K
CYAD
13172
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
$15.3K ﹤0.01%
16,285
-13,534
-45% -$15.3K
DCFC
13173
CALL
DELISTED
Tritium DCFC Limited Ordinary Shares
DCFC
$15.2K ﹤0.01%
60
-177
-75% -$51.8K
PTVE
13174
PUT
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$15.2K ﹤0.01%
1,900
-1,600
-46% -$16.5K
SUPV
13175
Grupo Supervielle
SUPV
$705M
$15.1K ﹤0.01%
6,704
-20,896
-76% -$54.2K

Similar funds

Ken Griffin's Q1 2023 Portfolio in Review

As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.

  • Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
  • Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
  • Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
  • Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
  • Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
  • Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
  • Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.